Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Nov 1;295(Pt 3):673–677. doi: 10.1042/bj2950673

Glucokinase activity in isolated islets from obese fa/fa Zucker rats.

C B Chan 1
PMCID: PMC1134612  PMID: 8240276

Abstract

Glucokinase (EC 2.7.1.2) activity of B-cells was measured in extracted pancreatic islets isolated from lean and obese fa/fa Zucker rats and maintained in primary culture overnight. Formation of [14C]glucose phosphoric esters from D-[U-14C]glucose was measured in the presence of unlabelled glucose from 0.05 to 0.50 mM for hexokinase (EC 2.7.1.1) activity, and 8.0-16.0 mM unlabelled glucose for glucokinase activity. Eadie-Hofstee analysis revealed that hexokinase kinetic parameters (Vmax and Km) for [14C]glucose phosphoric ester formation were similar in lean- and fa/fa-rat islets. For glucokinase, there was no difference in Vmax. between phenotypes. A non-significant tendency to increased sensitivity to glucose was noted in the fa/fa-rat islets (P = 0.13). In lean-rat islets, the glucokinase inhibitor mannoheptulose (3 mM) decreased Vmax. by 80% and increased the apparent Km from 3.3 +/- 0.7 mM to 12.2 +/- 2.0 mM (P < 0.05). There was no difference in Km or Vmax. in mannoheptulose-treated versus control islets from fa/fa rats. This lack of effect was consistent with reported effects of mannoheptulose on insulin secretion from fa/fa-rat islets [Chan, MacPhail and Mitton (1993) Can. J. Physiol. Pharmacol. 71, 34-39]. The data from glucose and mannoheptulose experiments support the hypothesis that glucokinase function is altered in fa/fa Zucker rats and may contribute to fasting hyperinsulinaemia in vivo in these animals.

Full text

PDF
673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedoya F. J., Ramírez R., Arilla E., Goberna R. Effect of 2-bromostearate on glucose-phosphorylating activities and the dynamics of insulin secretion in islets of Langerhans during fasting. Diabetes. 1984 Sep;33(9):858–863. doi: 10.2337/diab.33.9.858. [DOI] [PubMed] [Google Scholar]
  2. Bray G. A., York D. A., Fisler J. S. Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam Horm. 1989;45:1–125. doi: 10.1016/s0083-6729(08)60393-3. [DOI] [PubMed] [Google Scholar]
  3. Burch P. T., Trus M. D., Berner D. K., Leontire A., Zawalich K. C., Matschinsky F. M. Adaptation of glycolytic enzymes: glucose use and insulin release in rat pancreatic islets during fasting and refeeding. Diabetes. 1981 Nov;30(11):923–928. doi: 10.2337/diab.30.11.923. [DOI] [PubMed] [Google Scholar]
  4. Cawthorn E. G., Chan C. B. Effect of pertussis toxin on islet insulin secretion in obese (fa/fa) Zucker rats. Mol Cell Endocrinol. 1991 Mar;75(3):197–204. doi: 10.1016/0303-7207(91)90161-k. [DOI] [PubMed] [Google Scholar]
  5. Chan C. B., MacPhail R. M., Mitton K. Evidence for defective glucose sensing by islets of fa/fa obese Zucker rats. Can J Physiol Pharmacol. 1993 Jan;71(1):34–39. doi: 10.1139/y93-005. [DOI] [PubMed] [Google Scholar]
  6. Chan C. B., Pederson R. A., Buchan A. M., Tubesing K. B., Brown J. C. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat. Diabetes. 1984 Jun;33(6):536–542. doi: 10.2337/diab.33.6.536. [DOI] [PubMed] [Google Scholar]
  7. Chan C. B., Pederson R. A., Buchan A. M., Tubesing K. B., Brown J. C. Gastric inhibitory polypeptide and hyperinsulinemia in the Zucker (fa/fa) rat: a developmental study. Int J Obes. 1985;9(2):137–146. [PubMed] [Google Scholar]
  8. Curry D. L., Stern J. S. Dynamics of insulin hypersecretion by obese Zucker rats. Metabolism. 1985 Sep;34(9):791–796. doi: 10.1016/0026-0495(85)90100-3. [DOI] [PubMed] [Google Scholar]
  9. Feig S. A., Shohet S. B., Nathan D. G. Energy metabolism in human erythrocytes. I. Effects of sodium fluoride. J Clin Invest. 1971 Aug;50(8):1731–1737. doi: 10.1172/JCI106662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gidh-Jain M., Takeda J., Xu L. Z., Lange A. J., Vionnet N., Stoffel M., Froguel P., Velho G., Sun F., Cohen D. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1932–1936. doi: 10.1073/pnas.90.5.1932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hattersley A. T., Turner R. C., Permutt M. A., Patel P., Tanizawa Y., Chiu K. C., O'Rahilly S., Watkins P. J., Wainscoat J. S. Linkage of type 2 diabetes to the glucokinase gene. Lancet. 1992 May 30;339(8805):1307–1310. doi: 10.1016/0140-6736(92)91958-b. [DOI] [PubMed] [Google Scholar]
  12. Jeanrenaud B. Insulin and obesity. Diabetologia. 1979 Sep;17(3):133–138. doi: 10.1007/BF01219738. [DOI] [PubMed] [Google Scholar]
  13. Koranyi L. I., Tanizawa Y., Welling C. M., Rabin D. U., Permutt M. A. Human islet glucokinase gene. Isolation and sequence analysis of full-length cDNA. Diabetes. 1992 Jul;41(7):807–811. doi: 10.2337/diab.41.7.807. [DOI] [PubMed] [Google Scholar]
  14. Kuffert A., Stern J. S., Curry D. L. Pancreatic hypersensitivity to glucose by young obese Zucker rats (fa/fa). Metabolism. 1988 Oct;37(10):952–957. doi: 10.1016/0026-0495(88)90152-7. [DOI] [PubMed] [Google Scholar]
  15. Leclercq-Meyer V., Marchand J., Malaisse W. J. Anomeric specificity of the insulin and glucagon secretory responses to D-glucose in lean and obese Zucker rats. Pancreas. 1987;2(6):645–652. doi: 10.1097/00006676-198711000-00004. [DOI] [PubMed] [Google Scholar]
  16. Lenzen S., Panten U. Signal recognition by pancreatic B-cells. Biochem Pharmacol. 1988 Feb 1;37(3):371–378. doi: 10.1016/0006-2952(88)90201-8. [DOI] [PubMed] [Google Scholar]
  17. Liang Y., Najafi H., Matschinsky F. M. Glucose regulates glucokinase activity in cultured islets from rat pancreas. J Biol Chem. 1990 Oct 5;265(28):16863–16866. [PubMed] [Google Scholar]
  18. Liang Y., Najafi H., Smith R. M., Zimmerman E. C., Magnuson M. A., Tal M., Matschinsky F. M. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes. 1992 Jul;41(7):792–806. doi: 10.2337/diab.41.7.792. [DOI] [PubMed] [Google Scholar]
  19. Magnuson M. A., Shelton K. D. An alternate promoter in the glucokinase gene is active in the pancreatic beta cell. J Biol Chem. 1989 Sep 25;264(27):15936–15942. [PubMed] [Google Scholar]
  20. Malaisse W. J., Sener A. Glucokinase is not the pancreatic B-cell glucoreceptor. Diabetologia. 1985 Aug;28(8):520–527. doi: 10.1007/BF00281986. [DOI] [PubMed] [Google Scholar]
  21. Matschinsky F. M., Ellerman J. E. Metabolism of glucose in the islets of Langerhans. J Biol Chem. 1968 May 25;243(10):2730–2736. [PubMed] [Google Scholar]
  22. Matschinsky F. M. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes. 1990 Jun;39(6):647–652. doi: 10.2337/diab.39.6.647. [DOI] [PubMed] [Google Scholar]
  23. Meglasson M. D., Burch P. T., Berner D. K., Najafi H., Matschinsky F. M. Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreatic beta-cell. Diabetes. 1986 Oct;35(10):1163–1173. doi: 10.2337/diab.35.10.1163. [DOI] [PubMed] [Google Scholar]
  24. Meglasson M. D., Matschinsky F. M. New perspectives on pancreatic islet glucokinase. Am J Physiol. 1984 Jan;246(1 Pt 1):E1–13. doi: 10.1152/ajpendo.1984.246.1.E1. [DOI] [PubMed] [Google Scholar]
  25. Perley M. J., Kipnis D. M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects. J Clin Invest. 1967 Dec;46(12):1954–1962. doi: 10.1172/JCI105685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Permutt M. A., Chiu K. C., Tanizawa Y. Glucokinase and NIDDM. A candidate gene that paid off. Diabetes. 1992 Nov;41(11):1367–1372. doi: 10.2337/diab.41.11.1367. [DOI] [PubMed] [Google Scholar]
  27. Purrello F., Buscema M., Rabuazzo A. M., Caltabiano V., Forte F., Vinci C., Vetri M., Vigneri R. Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes. 1993 Jan;42(1):199–205. doi: 10.2337/diab.42.1.199. [DOI] [PubMed] [Google Scholar]
  28. Stoffel M., Froguel P., Takeda J., Zouali H., Vionnet N., Nishi S., Weber I. T., Harrison R. W., Pilkis S. J., Lesage S. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7698–7702. doi: 10.1073/pnas.89.16.7698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Svensson C., Welsh N., Krawetz S. A., Welsh M. Exhibition of specific alterations in activities and mRNA levels of rat islet glycolytic and mitochondrial enzymes in three different in vitro model systems for attenuated insulin release. Diabetes. 1991 Jun;40(6):771–776. doi: 10.2337/diab.40.6.771. [DOI] [PubMed] [Google Scholar]
  30. Tiedge M., Lenzen S. Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells. Biochem J. 1991 Nov 1;279(Pt 3):899–901. doi: 10.1042/bj2790899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Timmers K. I., Voyles N. R., Recant L. Genetically obese rats with (SHR/N-cp) and without diabetes (LA/N-cp) share abnormal islet responses to glucose. Metabolism. 1992 Oct;41(10):1125–1133. doi: 10.1016/0026-0495(92)90298-o. [DOI] [PubMed] [Google Scholar]
  32. Trus M. D., Zawalich W. S., Burch P. T., Berner D. K., Weill V. A., Matschinsky F. M. Regulation of glucose metabolism in pancreatic islets. Diabetes. 1981 Nov;30(11):911–922. doi: 10.2337/diab.30.11.911. [DOI] [PubMed] [Google Scholar]
  33. Vincent M. F., Bontemps F., Van den Berghe G. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes. Biochem J. 1992 Jan 1;281(Pt 1):267–272. doi: 10.1042/bj2810267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G. I., Zouali H., Lesage S., Velho G., Iris F., Passa P. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature. 1992 Apr 23;356(6371):721–722. doi: 10.1038/356721a0. [DOI] [PubMed] [Google Scholar]
  35. Watkins P. B., Schade R., Mills A. S., Carithers R. L., Jr, Van Thiel D. H. Fatal hepatic necrosis associated with parenteral gold therapy. Dig Dis Sci. 1988 Aug;33(8):1025–1029. doi: 10.1007/BF01536001. [DOI] [PubMed] [Google Scholar]
  36. Xu Z. X., Fox L., Melethil S., Winberg L., Badr M. Mechanism of aluminum-induced inhibition of hepatic glycolysis: inactivation of phosphofructokinase. J Pharmacol Exp Ther. 1990 Jul;254(1):301–305. [PubMed] [Google Scholar]
  37. Zawalich W. S., Dye E. S., Rognstad R., Matschinsky F. M. On the biochemical nature of triose- and hexose-stimulated insulin secretion. Endocrinology. 1978 Dec;103(6):2027–2034. doi: 10.1210/endo-103-6-2027. [DOI] [PubMed] [Google Scholar]
  38. Zucker L. M., Antoniades H. N. Insulin and obesity in the Zucker genetically obese rat "fatty". Endocrinology. 1972 May;90(5):1320–1330. doi: 10.1210/endo-90-5-1320. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES